{"id":2203,"date":"2026-09-24T01:10:00","date_gmt":"2026-09-23T16:10:00","guid":{"rendered":"https:\/\/onepress.co.kr\/index.php\/briefing\/2026-09-24-who-contraception-options-en\/"},"modified":"2026-09-24T01:10:00","modified_gmt":"2026-09-23T16:10:00","slug":"2026-09-24-who-contraception-options-en","status":"publish","type":"briefing","link":"https:\/\/onepress.co.kr\/index.php\/briefing\/2026-09-24-who-contraception-options-en\/","title":{"rendered":"WHO broadens contraception guidance across pills, implants and emergency options"},"content":{"rendered":"<p><strong>2026-09-24 01:10 KST<\/strong><\/p>\n<p>On 23 September WHO added guidance on extended or continuous combined pills, longer etonogestrel-implant use and mifepristone for emergency contraception.<\/p>\n<p>It called for more safety evidence on ormeloxifene and advised against adding quinestrol pills to national programmes because evidence is limited and serious adverse events have been reported.<\/p>\n<h2>How long?<\/h2>\n<p>Combined pills may be used in extended cycles up to six months or continuously up to one year; WHO supports etonogestrel implants for up to five years.<\/p>\n<h2>Emergency option<\/h2>\n<p>Mifepristone 10\u201350 mg is recommended as an additional option as soon as possible and within five days after unprotected sex. Availability is not automatic in every country.<\/p>\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" src=\"https:\/\/onepress.co.kr\/wp-content\/uploads\/2026\/09\/who-contraception-options-en.png\" alt=\"WHO broadens contraception guidance across pills, implants and emergency options\" loading=\"lazy\" \/><figcaption class=\"op-briefing-image-caption\">This AI-generated image explains the topic; it is not a photograph of an actual event, observation or field site.<\/figcaption><\/figure>\n<h2>Why choice matters<\/h2>\n<p>WHO estimates 164 million women wanting to delay or avoid pregnancy are not using contraception. More options may better match cost, visits, preferences and side effects.<\/p>\n<h2>What to check<\/h2>\n<p>Confirm the product, licensed duration, personal contraindications and local rules with a clinician. The guideline supports policy and clinical guidance; it does not replace individual care.<\/p>\n<h2>Primary source and independent checks<\/h2>\n<p>Primary source: <a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240124578\" target=\"_blank\" rel=\"noopener noreferrer\">WHO ECO guideline<\/a><\/p>\n<p>Institutional explanation: <a href=\"https:\/\/www.who.int\/news\/item\/23-09-2026-who-expands-safe-options-for-contraception\" target=\"_blank\" rel=\"noopener noreferrer\">WHO news release<\/a><\/p>\n<p>Independent check: <a href=\"https:\/\/www.quotidianosanita.it\/scienza-e-farmaci\/contraccezione-l-oms-amplia-le-possibilit-di-scelta-nuove-indicazioni-su-pillola-impianti-e-contraccezione-d-emergenza\/\" target=\"_blank\" rel=\"noopener noreferrer\">Quotidiano Sanit\u00e0<\/a><\/p>\n<h2>Read in other languages<\/h2>\n<p><a href=\"https:\/\/onepress.co.kr\/index.php\/briefing\/2026-09-24-who-contraception-options-ko\/\">\ud55c\uad6d\uc5b4<\/a> \u00b7 <a href=\"https:\/\/onepress.co.kr\/index.php\/briefing\/2026-09-24-who-contraception-options-en\/\">English<\/a> \u00b7 <a href=\"https:\/\/onepress.co.kr\/index.php\/briefing\/2026-09-24-who-contraception-options-es\/\">Espa\u00f1ol<\/a> \u00b7 <a href=\"https:\/\/onepress.co.kr\/index.php\/briefing\/2026-09-24-who-contraception-options-ja\/\">\u65e5\u672c\u8a9e<\/a> \u00b7 <a href=\"https:\/\/onepress.co.kr\/index.php\/briefing\/2026-09-24-who-contraception-options-vi\/\">Ti\u1ebfng Vi\u1ec7t<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>WHO assessed five methods or practices that were absent from, or differed from, earlier guidance. National approvals and individual medical eligibility still apply, so this is not advice to change a regimen without care.<\/p>\n","protected":false},"featured_media":0,"template":"","meta":[],"class_list":["post-2203","briefing","type-briefing","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/onepress.co.kr\/index.php\/wp-json\/wp\/v2\/briefing\/2203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onepress.co.kr\/index.php\/wp-json\/wp\/v2\/briefing"}],"about":[{"href":"https:\/\/onepress.co.kr\/index.php\/wp-json\/wp\/v2\/types\/briefing"}],"wp:attachment":[{"href":"https:\/\/onepress.co.kr\/index.php\/wp-json\/wp\/v2\/media?parent=2203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}